UPDATE : Monday, October 14, 2019
상단여백
Sillajen wins approval to start clinical trial in China
The China Food and Drug Administration (CFDA) has given the green light to ...
by Marian Chu  |  2017-07-20 13:43
라인
‘Stem cell therapy’s problem? No hit item yet’
Stem cells, which can be transplanted into a human body and differentiating...
by Nam Doo-hyun  |  2017-07-19 18:16
라인
Smaller firms lead domestic stem cell market
Big businesses and small- to medium-sized enterprises (SMEs) account for 17...
by Nam Doo-hyun  |  2017-07-05 13:49
라인
Janssen director points out flaws in Korean quality systems
“We need to provide a gap in quality systems and quality management for vac...
by Constance Williams  |  2017-06-30 17:09
라인
David and Goliath; how Korean pharmaceuticals should compete with multinational giants
When foreign experts look at the Korean pharmaceutical industry, they wonde...
by Marian Chu  |  2017-06-29 09:44
라인
Korean, US firms tie up to bring in Alzheimer treatment
DuchemBio Co. (CEO: Kim Jong-woo), the first Korean company that produced d...
by Constance Williams  |  2017-06-28 17:51
라인
Medytox’s overseas exchange program helps global advances
Medytox Inc. (CEO Jung Hyun-ho), Korea's largest maker of botulinum tox...
by Constance Williams  |  2017-06-28 16:43
라인
‘Global Bio Conference 2017’ opens for 3-day run at COEX
The “Global Bio Conference 2017 (GBC 2017)” kicked off its annual conferenc...
by Marian Chu  |  2017-06-28 16:30
라인
KISTI present ways to sharpen competitiveness of precision medicine
For precision medicine to take root in Korea, the nation needs to make a mo...
by Nam Doo-hyun  |  2017-06-23 13:35
라인
‘Korea needs to develop biomarkers for personalized medical services’
As the biomarker technology remains at a nascent stage in Korea, the indust...
by Nam Doo-hyun  |  2017-06-22 13:24
라인
'Bio ventures are for developing new drugs, not making cosmetics'
Bio ventures promoting cosmetic products while claiming to carry the banner...
by Nam Doo-hyun  |  2017-06-19 14:47
라인
New government set to streamline healthcare R&D projects
The Moon Jae-in administration, which is busy setting up specific strategie...
by Nam Doo-hyun  |  2017-06-15 11:05
라인
Sewon Cellontech’s cartilage-restoring device wins Europe‘s patent
Sewon Cellontech has completed its patent registration in 35 countries in E...
by Constance Williams  |  2017-06-08 17:28
라인
Government publishes report on ‘genome editing’
The Ministry of Food and Drug Safety published a report Thursday on “genome...
by Constance Williams  |  2017-06-08 15:47
라인
Celltrion’s anticancer biosimilar as effective, safe as original drug
Herzuma, Celltrion’s antibody biosimilar used to treat breast and gastric c...
by Marian Chu  |  2017-06-05 15:49
라인
Sewon Cellontech’s cartilage-restoring therapy wins Canadian patent
Sewon Cellontech세원셀론텍’s manufacturing technology of CartiZol (collagen-base...
by Constance Williams  |  2017-05-31 11:05
라인
Macrogen, KAHP to build disease-predicting big data
Macrogen, a precision medical biotechnology company, and the Korea Associat...
by Constance Williams  |  2017-05-26 16:14
라인
Patent war looming over genome editing tech
The recent U.S. ruling regarding the patent dispute over the original techn...
by Nam Doo-hyun  |  2017-05-25 14:12
라인
Medipost wins UK patent for stem-cell treatment of Alzheimer’s
Medipost (CEO Yang Yoon-sun양윤선) has obtained a patent in the United Kingdom...
by Marian Chu  |  2017-05-18 15:01
라인
Government’s bio investment focuses on new drugs
The government has funneled about 10 percent of its fiscal spending on the ...
by Nam Doo-hyun  |  2017-05-12 13:55
여백
여백
여백
Back to Top